07:00 , May 29, 2001 |  BioCentury  |  Finance

Gravity well for money

Henri Meier's new gig as president of the board of directors at HBM BioVentures may be the Swiss epitome of the marriage of biotech and finance. The former CFO of F. Hoffmann-La Roche (SWX:ROCZ), Meier...
07:00 , Oct 16, 2000 |  BC Extra  |  Financial News

Idea raises EUR15 million

Idea (Munich, Germany), a developer of non-invasive therapeutics and vaccines given through the skin and nose, raised EUR15 million ($13 million) in a venture financing. Investors included 3i; TechnoStart; Technologieholding-Fonds; BB BioVentures; German Venture Capital...
07:00 , Oct 16, 2000 |  BioCentury  |  Finance

Shave and a haircut...

The market's weakness is taking its toll on some offerings. DrugAbuse Sciences withdrew its beleaguered 4 million share IPO and most of the new paper is getting out at lower valuations than targeted. DrugAbuse may...
07:00 , Jul 31, 2000 |  BC Extra  |  Financial News

Atugen raises EUR 20 million

The gene target identification and validation company Atugen (Berlin, Germany) raised EUR 20 million ($18.7 million) through a private second round financing. Investors included Apax Partners; BB BioVentures; and tbg Technologie-Beteiligungs-Gesellschaft....
07:00 , Oct 25, 1999 |  BioCentury  |  Finance

An IPO might as well be big

Even though the biotech group is off 9 percent in the last 6 weeks, companies and bankers apparently believe that the market is ready to accept IPO paper, as four sizable deals now stand in...
08:00 , Dec 21, 1998 |  BioCentury  |  Finance

Wasting assets

Wasting assets By contrast, Corixa (CRXA) last week scooped up Anergen (ANRG) for $8.5 million in shares. ANRG, which had $2.4 million in cash at Sept. 30, has two products in the clinic and adds...
08:00 , Mar 9, 1998 |  BioCentury  |  Finance

The eagle flies on Thursday

Although formal completion of the SBC Warburg Dillon Read/UBS Securities merger is slated for early May, the game of musical chairs has started. Thursday will be a critical day: that's when bonus checks for 1997...
08:00 , Dec 22, 1997 |  BioCentury  |  Finance

Limping

With the BioCentury 100 Price Level Index falling another 2 percent last week (it's down nearly 22 percent since early October), three IPOs fell victim to the soft market. Centocor Diagnostics, RTP Pharma, and Cerep...
08:00 , Nov 3, 1997 |  BioCentury  |  Finance

Private Rounds: Ice pack

While the public markets were in meltdown, a number of privately owned European companies were either completing or announcing financing rounds. Biotrin Holdings was expected to announce today completion of its third round of financing,...
07:00 , Oct 20, 1997 |  BioCentury  |  Finance

Attention getting

Innogenetics has provided EASDAQ's detractors with evidence that traders can show up on the pan-European exchange. After stagnating for almost a year, INNX (Ghent, Belgium) burst into activity in the past two weeks, its share...